Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2004

Feb 6, 2004

34519_dirs_2004-02-06_5ef51046-9fca-4ab4-8a17-9c8104a14864.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2004-02-04

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-02-04 Common Stock, par value $0.10 per share P 500 $3.95 Acquired 351160 Direct
2004-02-04 Common Stock, par value $0.10 per share P 300 $3.96 Acquired 351460 Direct
2004-02-04 Common Stock, par value $0.10 per share P 300 $3.96 Acquired 351760 Direct
2004-02-04 Common Stock, par value $0.10 per share P 700 $3.95 Acquired 352460 Direct
2004-02-05 Common Stock, par value $0.10 per share P 500 $3.95 Acquired 352960 Direct
2004-02-05 Common Stock, par value $0.10 per share P 400 $3.94 Acquired 353360 Direct
2004-02-06 Common Stock, par value $0.10 per share P 900 $3.96 Acquired 354260 Direct
2004-02-06 Common Stock, par value $0.10 per share P 500 $4.01 Acquired 354760 Direct
2004-02-06 Common Stock, par value $0.10 per share P 500 $4.01 Acquired 355260 Direct

Footnotes

F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.